Clinical Trial Update: A Study to Evaluate the Effectiveness of Voriconazole + Micafungin Versus Voriconazole Alone for Invasive Aspergillosis [Phase 4]

View source ↗

Summary

This Phase 4 trial evaluating voriconazole plus micafungin versus voriconazole alone for invasive aspergillosis has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aspergillosis
• Invasive Aspergillosis

Drugs mentioned

• Micafungin (micafungin)
• VORICONAZOLE (Voriconazole)

Snippet

Sponsor: Astellas Pharma Inc | Conditions: Aspergillosis/Blood, Aspergillosis/Invasive | Phase 4 | Status: WITHDRAWN